Women and men are equally disabled by Charcot-Marie-Tooth disease type 1A

Neurology

Volumn 68, Issue 11, 2007, Pages 873-

  Swan, Emily R ^a   Fuerst, Darren R ^a   Shy, Michael E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE;

ADULT; AGE DISTRIBUTION; ARTICLE; CHARCOT MARIE TOOTH DISEASE TYPE 1A; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; PREGNANCY; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL ANALYSIS; SYMPTOM; WALKING AID; BLOOD; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY;

ADULT; CHARCOT-MARIE-TOOTH DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY; PROGESTERONE; SEVERITY OF ILLNESS INDEX;

EID: 34047210187     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000256818.43819.da     Document Type: Article

References (5)

1. Sereda MW, Meyer Zu Horste G, Suter U, Uzma M, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 2003;12:1533-1537.
2. Shy ME, Blake J, Krajewski K, et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005;64:1209-1214.
3. Shy ME, Siskind C, Swan ER, et al. CMT1X phenotypes represent loss of GJB1 gene function. Neurology 2007;68:849-855.
4. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 1995;45:1115-1121.
5. Mahesh VB, Brann DW, Hendry LB. Diverse modes of action of progesterone and its metabolites. J Steroid Biochem Mol Biol 1996;56:209-219.